Jaypirca 50 mg film-coated tablets

DRUG2 trials

Sponsors

Genmab A/S, Newave Pharmaceutical Inc.

Conditions

Chronic Lymphocytic LeukemiaRelapsed or Refractory Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)

Phase 1

A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

RecruitingCTIS2023-504828-25-00

Genmab A/SChronic Lymphocytic Leukemia

Start: 2020-11-16Target: 125Updated: 2025-11-20

Phase 3

A Phase 3 Open-Label, Randomized, Multicenter Study of Rocbrutinib (LP-168) vs Pirtobrutinib in Covalent BTK Inhibitor (cBTKi) Pretreated Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) Subjects

Not yet recruitingCTIS2026-525656-28-00

Newave Pharmaceutical Inc.Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)

Target: 11Updated: 2026-10-20